Literature DB >> 22821391

Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis.

Takashi Takei1, Mitsuyo Itabashi, Takahito Moriyama, Ari Shimizu, Yuki Tsuruta, Ayami Ochi, Kayu Nakayama, Chihiro Iwasaki, Keiko Uchida, Kosaku Nitta.   

Abstract

BACKGROUND: Pathogenesis and clinical prognosis of membranoproliferative glomerulonephritis (MPGN) has not yet been established.
METHODS: We conducted a retrospective study of 41 patients with MPGN (type I and III) and examined the renal survival. In addition, factors contributing to survival time were analyzed.
RESULTS: Fourteen patients (34 %) were classified into the renal death group. Patients with nephrotic syndrome and positive C1q staining of glomerular deposits showed a particularly poor prognosis. Significantly higher frequency of nephrotic syndrome and higher urinary protein excretion were observed in the renal death group (p = 0.0002, p = 0.0002) than in the renal survival group. The intensity of C1q staining was positively correlated with the severity of the proteinuria (p = 0.004). Factors that influenced the survival time were positive C1q staining of glomerular deposits (p = 0.003), presence of nephrotic syndrome (p = 0.004), serum albumin (p = 0.02), and proteinuria (p = 0.04).
CONCLUSIONS: C1q staining in glomerular deposits and nephrotic syndrome were important factors influencing the prognosis and outcome in MPGN patients. C1q deposition may play a key role in the pathogenesis of MPGN, as evidenced by numerous observations, such as induction of proteinuria.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22821391     DOI: 10.1007/s10157-012-0667-6

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  28 in total

1.  Dense deposit disease: a variant of membranoproliferative glomerulonephritis.

Authors:  R Habib; M C Gubler; C Loirat; H B Mäiz; M Levy
Journal:  Kidney Int       Date:  1975-04       Impact factor: 10.612

Review 2.  Membranoproliferative glomerulonephritis.

Authors:  L Nakopoulou
Journal:  Nephrol Dial Transplant       Date:  2001       Impact factor: 5.992

3.  Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.

Authors:  M C Braun; C D West; C F Strife
Journal:  Am J Kidney Dis       Date:  1999-12       Impact factor: 8.860

4.  Spontaneous improvement in a case of C1q nephropathy.

Authors:  M Nishida; H Kawakatsu; H Komatsu; K Ishiwari; M Tamai; T Sawada
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

5.  [Long-term evolution of membranoproliferative glomerulonephritis in adults : spontaneous clinical remission in 13 cases with proven regression of glomerular lesions in 5 cases (author's transl)].

Authors:  D Droz; L H Noel; C Barbanel; J P Grünfeld
Journal:  Nephrologie       Date:  1982

6.  Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.

Authors:  Leendert A Trouw; Tom W L Groeneveld; Marc A Seelen; Jacques M G J Duijs; Ingeborg M Bajema; Frans A Prins; Uday Kishore; David J Salant; J Sjef Verbeek; Cees van Kooten; Mohamed R Daha
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

7.  Immunosuppressive treatment of membranoproliferative glomerulonephritis.

Authors:  R Faedda; A Satta; F Tanda; M Pirisi; E Bartoli
Journal:  Nephron       Date:  1994       Impact factor: 2.847

Review 8.  A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases.

Authors:  Laura Barisoni; H William Schnaper; Jeffrey B Kopp
Journal:  Clin J Am Soc Nephrol       Date:  2007-04-11       Impact factor: 8.237

Review 9.  Dense deposit disease: new insights.

Authors:  Patrick D Walker
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-05       Impact factor: 2.894

10.  Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases.

Authors:  H Schmitt; A Bohle; T Reineke; D Mayer-Eichberger; W Vogl
Journal:  Nephron       Date:  1990       Impact factor: 2.847

View more
  1 in total

1.  Characteristics of membranoproliferative glomerulonephritis based on a new classification at a single center.

Authors:  Marie Nakano; Kazunori Karasawa; Takahito Moriyama; Keiko Uchida; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2019-03-11       Impact factor: 2.801

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.